|
PIK3C3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.49919999999459E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.230500E-02 |
| Normal-vs-Stage2 |
1.115950E-01 |
| Normal-vs-Stage3 |
5.88880000318426E-09 |
| Normal-vs-Stage4 |
1.42520000001589E-06 |
| Stage1-vs-Stage2 |
5.103800E-01 |
| Stage1-vs-Stage3 |
4.37019999999233E-06 |
| Stage1-vs-Stage4 |
5.024800E-04 |
| Stage2-vs-Stage3 |
3.394400E-02 |
| Stage2-vs-Stage4 |
4.781700E-02 |
| Stage3-vs-Stage4 |
9.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.74819999999776E-05 |
| Normal-vs-AfricanAmerican |
3.215600E-02 |
| Normal-vs-Asian |
6.691600E-01 |
| Caucasian-vs-AfricanAmerican |
8.610800E-01 |
| Caucasian-vs-Asian |
6.338200E-01 |
| AfricanAmerican-vs-Asian |
6.595600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87429999970657E-07 |
| Normal-vs-Female |
8.493800E-02 |
| Male-vs-Female |
4.600200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.819800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.513600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.01780000047758E-07 |
| Normal-vs-Age(81-100Yrs) |
7.477600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.784600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.894400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.953000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.336220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.992800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.019800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.459810E-01 |
| Normal-vs-Grade 2 |
1.636380E-01 |
| Normal-vs-Grade 3 |
9.881600004924E-08 |
| Normal-vs-Grade 4 |
1.58030000196874E-09 |
| Grade 1-vs-Grade 2 |
8.579900E-02 |
| Grade 1-vs-Grade 3 |
1.752090E-02 |
| Grade 1-vs-Grade 4 |
4.883900E-03 |
| Grade 2-vs-Grade 3 |
1.045360E-04 |
| Grade 2-vs-Grade 4 |
6.07229999949332E-07 |
| Grade 3-vs-Grade 4 |
1.862450E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.075200E-01 |
| Normal-vs-ccB subtype |
5.66140001545534E-09 |
| ccA subtype-vs-ccB subtype |
7.52930051639566E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.398090E-03 |
| Normal-vs-N1 |
7.439800E-02 |
| N0-vs-N1 |
2.866000E-01 |
|
|
